SHG vs. NVS
SHG (Shinhan Financial Group Co., Ltd.) and NVS (Novartis AG) are both stocks. SHG operates in Banks - Regional (Financial Services), while NVS operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SHG returned 10.16%/yr vs 11.14%/yr for NVS. At a 0.26 correlation, their price movements are largely independent.
Performance
SHG vs. NVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SHG achieves a 25.49% return, which is significantly higher than NVS's 14.40% return. Over the past 10 years, SHG has underperformed NVS with an annualized return of 10.16%, while NVS has yielded a comparatively higher 11.14% annualized return.
SHG
- 1D
- 2.62%
- 1M
- 4.73%
- YTD
- 25.49%
- 6M
- 26.79%
- 1Y
- 55.63%
- 3Y*
- 39.87%
- 5Y*
- 16.63%
- 10Y*
- 10.16%
NVS
- 1D
- -0.55%
- 1M
- 2.22%
- YTD
- 14.40%
- 6M
- 18.98%
- 1Y
- 30.60%
- 3Y*
- 19.57%
- 5Y*
- 14.77%
- 10Y*
- 11.14%
SHG vs. NVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SHG Shinhan Financial Group Co., Ltd. | 25.49% | 68.28% | 12.80% | 15.25% | -4.61% | 5.27% | -21.83% | 7.27% | -23.51% | 23.27% |
NVS Novartis AG | 14.40% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 5.95% | 19.42% |
Correlation
The correlation between SHG and NVS is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Sep 16, 2003 | 0.26 |
Fundamentals
SHG:
$32.47B
NVS:
$293.28B
SHG:
₩10.58K
NVS:
$6.99
SHG:
9.67
NVS:
21.90
SHG:
1.13
NVS:
1.48
SHG:
1.42
NVS:
5.29
SHG:
0.84
NVS:
7.62
SHG:
₩34.80T
NVS:
$56.05B
SHG:
₩16.62T
NVS:
$42.19B
SHG:
₩8.32T
NVS:
$22.40B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SHG vs. NVS — Risk / Return Rank
SHG
NVS
SHG vs. NVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Shinhan Financial Group Co., Ltd. (SHG) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SHG | NVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.36 | ||
| Sortino ratioReturn per unit of downside risk | +0.48 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.26 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 3.10 | 2.43 | +0.67 |
| Martin ratioReturn relative to average drawdown | 8.52 | 5.88 | +2.64 |
Loading charts...
Drawdowns
SHG vs. NVS - Drawdown Comparison
The maximum SHG drawdown since its inception was -82.02%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for SHG and NVS.
Loading charts...
Drawdown Indicators
| SHG | NVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.02% | -42.10% | -39.92% |
Max Drawdown (1Y)Largest decline over 1 year | -18.03% | -12.65% | -5.38% |
Max Drawdown (3Y)Largest decline over 3 years | -35.19% | -19.95% | -15.24% |
Max Drawdown (5Y)Largest decline over 5 years | -35.39% | -20.42% | -14.97% |
Max Drawdown (10Y)Largest decline over 10 years | -65.50% | -26.03% | -39.47% |
Current DrawdownCurrent decline from peak | -6.16% | -6.46% | +0.30% |
Average DrawdownAverage peak-to-trough decline | -33.81% | -10.92% | -22.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.55% | 5.23% | +1.32% |
Volatility
SHG vs. NVS - Volatility Comparison
Shinhan Financial Group Co., Ltd. (SHG) has a higher volatility of 10.18% compared to Novartis AG (NVS) at 7.18%. This indicates that SHG's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SHG | NVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.18% | 7.18% | +3.00% |
Volatility (6M)Calculated over the trailing 6-month period | 23.12% | 14.96% | +8.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.55% | 21.02% | +9.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.99% | 18.89% | +11.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.34% | 19.64% | +10.70% |
Dividends
SHG vs. NVS - Dividend Comparison
SHG's dividend yield for the trailing twelve months is around 0.61%, less than NVS's 3.12% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVS Novartis AG | 3.12% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
SHG Shinhan Financial Group Co., Ltd. | 0.61% | 2.24% | 5.96% | 3.87% | 5.54% | 1.54% | 0.00% | 0.00% | 0.00% | 0.00% | 3.35% | 3.10% |
Financials
SHG vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Shinhan Financial Group Co., Ltd. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SHG vs. NVS - Profitability Comparison
SHG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Shinhan Financial Group Co., Ltd. reported a gross profit of 4.19T and revenue of 8.73T. Therefore, the gross margin over that period was 48.0%.
NVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.
SHG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Shinhan Financial Group Co., Ltd. reported an operating income of 2.29T and revenue of 8.73T, resulting in an operating margin of 26.2%.
NVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.
SHG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Shinhan Financial Group Co., Ltd. reported a net income of 1.62T and revenue of 8.73T, resulting in a net margin of 18.6%.
NVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.
Frequently Asked Questions
SHG and NVS have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SHG has higher volatility (10.18%) compared to NVS (7.18%). In terms of maximum drawdown, SHG dropped -82.02% vs NVS's -42.10%.
SHG currently has the higher Sharpe Ratio (1.83 vs 1.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SHG and NVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer